Malignant neoplasm of urinary bladder
|
0.300 |
Biomarker
|
disease |
CTD_human |
Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.
|
26039340 |
2015 |
Bladder Neoplasm
|
0.300 |
Biomarker
|
disease |
CTD_human |
Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.
|
26039340 |
2015 |
Rheumatoid Arthritis
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
|
31407831 |
2019 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Marginal Zone B-Cell Lymphoma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
|
31407831 |
2019 |
Lymphocyte Count measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
The combination of a genome-wide association study of lymphocyte count and analysis of gene expression data reveals novel asthma candidate genes.
|
22286170 |
2012 |
Choriocarcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
What is more, miR-218-mediated Fbxw8 regulation was required for MALAT1-induced choriocarcinoma cell proliferation.
|
29096355 |
2018 |
Choriocarcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Taken together, these findings will shed light the role to mechanism of miR-218 in regulating JEG-3 cells proliferation via miR-218/Fbxw8 axis, and miR-218 may serve as a novel potential therapeutic target in human choriocarcinoma in the future.
|
24973709 |
2014 |
Fetal Growth Retardation
|
0.030 |
AlteredExpression
|
phenotype |
BEFREE |
Although no significant changes in expression levels of Fbxw8 or Cul7 were noted in IUGR compared with control placentas, Fbxw8 expression correlated negatively with gestational age in the control, but not in the IUGR group.
|
22524683 |
2012 |
Choriocarcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Silencing of Fbxw8 expression by siRNA inhibited the growth of choriocarcinoma JEG-3 cells.
|
20878477 |
2011 |
Fetal Growth Retardation
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Mice lacking Fbxw8 exhibit pathological defects in placenta and embryo similar to fetal growth retardation, suggesting a role of Fbxw8 in placentation.
|
20878477 |
2011 |
Fetal Growth Retardation
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Fbxw8-/- embryos show intrauterine growth retardation and abnormal development of the placenta, characterized by both a reduced thickness of the spongiotrophoblast layer and abnormal vessel structure in the labyrinth layer.
|
16880526 |
2006 |
Malignant neoplasm of breast
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Frameshift mutation FBXW8 c.1312_1313delGT was considered functionally relevant and was investigated for its potential association with breast cancer risk through subsequent genotyping in two hospital-based breast cancer case-control series from Belarus and Germany, respectively, comprising a total of 2740 breast cancer cases and 2174 controls.
|
29310837 |
2018 |
Malignant neoplasm of prostate
|
0.010 |
Biomarker
|
disease |
BEFREE |
There was a negative association between the expression of miR-3160-5p and F-box and WD repeat domain containing 8 (Fbxw8) in prostate cancer DU145 cells.
|
29805667 |
2018 |
Prostate carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
There was a negative association between the expression of miR-3160-5p and F-box and WD repeat domain containing 8 (Fbxw8) in prostate cancer DU145 cells.
|
29805667 |
2018 |
Breast Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Frameshift mutation FBXW8 c.1312_1313delGT was considered functionally relevant and was investigated for its potential association with breast cancer risk through subsequent genotyping in two hospital-based breast cancer case-control series from Belarus and Germany, respectively, comprising a total of 2740 breast cancer cases and 2174 controls.
|
29310837 |
2018 |
Nephroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In addition, we found that protein kinase B (AKT)-phosphorylated cugWT1 on Ser62 and protected cugWT1 from proteasomal degradation induced by the F-box/WD repeat-containing protein 8 (FBXW8).
|
29040381 |
2017 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
In this review, we will focus on β-TrCP (β-transducin repeat-containing protein) and two other prototypical mammalian F-box proteins, Fbxw7 and Fbxw8, in pancreatic tumorigenesis and progression.
|
26384530 |
2016 |
Presenile dementia
|
0.010 |
Biomarker
|
disease |
BEFREE |
These associations implicate genes related to apoptosis (HRK), development (WIF1), oxidative stress (MSR3B), ubiquitination (FBXW8) and neuronal migration (ASTN2), as well as enzymes targeted by new diabetes medications (DPP4), indicating new genetic influences on hippocampal size and possibly the risk of cognitive decline and dementia.
|
22504421 |
2012 |
Mental deterioration
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
These associations implicate genes related to apoptosis (HRK), development (WIF1), oxidative stress (MSR3B), ubiquitination (FBXW8) and neuronal migration (ASTN2), as well as enzymes targeted by new diabetes medications (DPP4), indicating new genetic influences on hippocampal size and possibly the risk of cognitive decline and dementia.
|
22504421 |
2012 |
Impaired cognition
|
0.010 |
Biomarker
|
disease |
BEFREE |
These associations implicate genes related to apoptosis (HRK), development (WIF1), oxidative stress (MSR3B), ubiquitination (FBXW8) and neuronal migration (ASTN2), as well as enzymes targeted by new diabetes medications (DPP4), indicating new genetic influences on hippocampal size and possibly the risk of cognitive decline and dementia.
|
22504421 |
2012 |
Dementia
|
0.010 |
Biomarker
|
disease |
BEFREE |
These associations implicate genes related to apoptosis (HRK), development (WIF1), oxidative stress (MSR3B), ubiquitination (FBXW8) and neuronal migration (ASTN2), as well as enzymes targeted by new diabetes medications (DPP4), indicating new genetic influences on hippocampal size and possibly the risk of cognitive decline and dementia.
|
22504421 |
2012 |